Terumo

Happy New Year! FY2025 marks a significant milestone in our journey. As we step into the fourth year of our 5-Year #Growth Strategy, GS26, we are on track to achieve one of our major goals. This reflects our collective dedication to advancing #healthcare through #innovation, but also brings greater expectations and responsibilities. At Terumo, we remain united by our purpose: delivering life-saving products and services to where they are needed, when they are needed. As “One Terumo,” we will continue evolving our technologies and creating solutions that bring tangible benefits to patients and society, while upholding our commitments to #sustainability, DE&I, and community contributions. Here’s to a year of growth, innovation, and positive impact. Let’s make 2025 extraordinary together!

As we bid farewell to 2024, we want to express our heartfelt #gratitude to all of you for being an essential part of Terumo’s journey. This year has highlighted the incredible dedication of our associates and partners worldwide toward our #mission of “Contributing to Society through Healthcare.” As we look ahead to 2025, we envision a year filled with new #opportunities and continued growth—together with all of you. For now, we hope you have cherish moments with your loved ones. Wishing you a joyful holiday season and a prosperous new year! #ThankYou

#Terumo global leaders from various regions, companies, and business functions, gathered in Tokyo, Japan for the “Global Leadership Meeting 2024” (GLM).   In the 2021, Terumo announced its "5-Year Growth Strategy with a 10-Year Vision" (GS26), which focuses on a new innovation strategy called "From Devices to Solutions." While working towards achieving our GS26 goals, it is equally important to prepare for our future beyond GS26. The discussions at this year's GLM served as a foundation for our ongoing contribution to global healthcare.   With over 30 leaders present, we had significant discussions on enhancing our presence in the healthcare field amidst the unprecedented acceleration of environmental changes. #Leadership #global #Leaders 

🌍 Terumo Group Procurement Policy 🌍 #Terumo strives to be a reliable healthcare company worldwide and promote corporate activities under the Group Mission of “Contributing to Society through Healthcare.” In our procurement activity, we adhere to the "Terumo Group Procurement Policy," and committed to respect of human rights and environmental protection while ensuring the quality and stable supply of goods and services. With a strong ethical foundation, we promote fair and transparent transactions. As we move forward, Terumo remains dedicated to earning the trust of healthcare providers and recipients worldwide.

Over 30,000 #Terumo associates contributing to global healthcare Globally, more than 30,000 associates, work across 30 production system and 22 R&D centers. Our associates embody our Group Mission "Contributing to Society through Healthcare," approaching their work with integrity and passion. Terumo will continue to pursue innovation with a strong sense of purpose, dedicated to making a meaningful impact on global healthcare.

Over 50,000 products to meet the needs of medical settings around the world At #Terumo, we are dedicated to delivering valuable products and services across the globe, driven by our commitment to innovation and the desire to provide safe and reliable healthcare solutions. With a portfolio that exceeds 50,000 products, we address the diverse needs of healthcare professionals around the world. Moving forward, Terumo is unwavering in its pursuit of excellence—not only in product quality and variety but also in supply and service. We are committed to enhancing the quality of every aspect of our operations.

Taking on the challenge of global healthcare through education and training Based on the belief that "medical devices are only fully effective when used correctly," Terumo has been committed to providing information to healthcare professionals on the proper use of medical devices as its responsibility as a medical device manufacturer.  Training facilities have been installed at Terumo's overseas bases, and 16 training facilities in 12 countries around the world support the global dissemination of therapeutic techniques.  We will continue to contribute to safe and secure medical care, aiming to solve globally expanding medical issues and improve the quality of medical care. https://lnkd.in/ghEvEAEz

📢 We are proud to announce our strategic partnership with Terumo Medical Products (Hangzhou) to produce high-quality medical products for the Chinese market. “China is a pivotal market for Terumo BCT and the entire Terumo Group,” said Antoinette Gawin, President and CEO. “With our ‘in China, for China’ approach, we are committed to our long-term growth here. By 2025, we plan to invest USD 15 million to expand our business and localized manufacturing, enhancing our ability to meet the evolving needs of Chinese customers and improve patient outcomes in China.” Read more here: https://bit.ly/4fIUHiQ #PatientCare #OneTerumo #China

Breaking Boundaries: Terumo R&D Engineers Unite at GTF2024 Innovation is the heartbeat of Terumo. On October 31- November 1, our R&D engineers from all the business units and Corporate R&D converged at the "Global Technology Fair 2024" (GTF2024) aimed to share technical advancement, and to seek collaboration for the next innovations for the upcoming 10 years.  In poster sessions, our R&D engineers made brilliant presentation of their research activities for all the attendees including business leaders and executives. The panel session was filled with learnings from collaboration as one Terumo R&D. #Science #Research #Development #Technology #Collaboration

#Terumo has announced its financial results for the second quarter of the fiscal year ending March 31, 2025 More information can be found here: https://lnkd.in/gRjTvkUM